Overview of Dr. Hu
Dr. Rachel Hu is an oncologist in Murray, UT and is affiliated with Intermountain Medical Center. She received her medical degree from University of Missouri-Columbia School of Medicine and has been in practice 2 years. She is one of 56 doctors at Intermountain Medical Center who specialize in Oncology. She has 8 publications and 49 citings.
Education & Training
Cleveland Clinic FoundationChief Fellow, Hematology/Oncology, 2018 - 2020
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
Duke University HospitalResidency, Internal Medicine, 2014 - 2017
Duke University HospitalInternship, Internal Medicine, 2014 - 2015
University of Missouri-Columbia School of MedicineClass of 2014
Purdue UniversityBS, Pharmaceutical Sciences, Summa Cum Laude, 2006 - 2010
Certifications & Licensure
UT State Medical License 2020 - 2026
NV State Medical License 2022 - 2025
ID State Medical License 2022 - 2024
WY State Medical License 2022 - 2024
OH State Medical License 2017 - 2021
NC State Medical License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Medical Society
- Rho Chi Pharmacy Honor Society
- Clinical Instructor Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 2020
Clinical Trials
Publications & Presentations
PubMed
Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.
Rachel Hu, Wei Wei, Agrima Mian, Kristen Gonter-Aubin, Charlene Kabel, Anthony Mato, Deborah M Stephens, Ashley Hanlon, Sirin Khajavian, Mazyar Shadman, Danielle Brand...> ;European Journal of Haematology. 2022 May 1- 9 citations
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J Voorhees, Natalie S Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T...> ;Blood Advances. 2021 Sep 28 - 6 citations
The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma
Rachel Hu, Allison M. Winter, Brian T. Hill> ;Current Oncology Reports. 2019 Apr 2 - Join now to see all
Abstracts/Posters
Lectures
Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia Patients at First Relapse: A Multi-Center Outcomes Analysis
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
